Home › Triple-Negative Breast Cancer › Florida › Orlando

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Orlando, FL

Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

Advent Health, Orlando

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

AdventHealth Cancer Institute, Orlando

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Nagre-recruitPhase 3

Orlando Health Cancer Institute ( Site 0012), Orlando
AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Nagre-recruitPhase 3

Orlando Health Cancer Institute ( Site 0030), Orlando
AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3

AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Sara Cannon Research Institute Lake Nona, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Nagre-recruitPhase 1

Advent Health Medical Group Radiation Oncology at Central Florida, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07020117

SMP-3124LP in Adults With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Advent Health, Celebration · 17 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06526819

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Nagre-recruitPhase 1

Florida Cancer Specialists - Lake Nona, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06150664

A Study of LY4175408 in Participants With Advanced Cancer

Nagre-recruitPhase 1

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

Nagre-recruitPhase 1

Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06545331

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa Orlando

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.